NBVM GP, LLC - 31 May 2023 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Reporting relationship: 10%+ Owner
Issuer ticker: LYRA
Reported as of: 31 May 2023
Net transaction value: +$4,499,999
SEC form: 4
Accepted by SEC: 02 Jun 2023, 16:15:21 UTC
Prior SEC filing: 14 Apr 2022
Source filing: View source filing
Reporting owner signature: North Bridge Venture Partners V-A, L.P., /s/ Edward T. Anderson, Manager of NBVM GP, general partner of North Bridge Venture Management V, L.P., general partner of North Bridge Venture Partners V-A, L.P.

Key filing fact

NBVM GP, LLC filed Form 4 for Lyra Therapeutics, Inc. (LYRA) on 02 Jun 2023.

Key facts

This page summarizes NBVM GP, LLC's Form 4 filing for Lyra Therapeutics, Inc. (LYRA).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 02 Jun 2023, 16:15.

Change

Previous filing in this sequence was filed on 14 Apr 2022.
Current net transaction value: +$4,499,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LYRA transaction

Common Stock

Purchase

Transaction value: $981,375
Shares: +403,858
Change %: +22%
Price: $2.43
Shares after: 2,259,301
Date: 31 May 2023
Ownership: See footnote
Footnotes: F1, F2

LYRA transaction

Common Stock

Purchase

Transaction value: $481,009
Shares: +197,946
Change %: +22%
Price: $2.43
Shares after: 1,107,370
Date: 31 May 2023
Ownership: See footnote
Footnotes: F1, F3

LYRA transaction

Common Stock

Purchase

Transaction value: $2,924,777
Shares: +1,203,612
Change %: +91%
Price: $2.43
Shares after: 2,521,745
Date: 31 May 2023
Ownership: See footnote
Footnotes: F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LYRA transaction Derivative

Warrant to purchase Common Stock

Purchase

Transaction value: $25,241
Shares: +201,929
Change %
Price: $0.1250^*
Shares after: 201,929
Date: 31 May 2023
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 201,929
Exercise price: $2.67
Footnotes: F1, F2

LYRA transaction Derivative

Warrant to purchase Common Stock

Purchase

Transaction value: $12,372
Shares: +98,973
Change %
Price: $0.1250^*
Shares after: 98,973
Date: 31 May 2023
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 98,973
Exercise price: $2.67
Footnotes: F1, F3

LYRA transaction Derivative

Warrant to purchase Common Stock

Purchase

Transaction value: $75,226
Shares: +601,806
Change %
Price: $0.1250^*
Shares after: 601,806
Date: 31 May 2023
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 601,806
Exercise price: $2.67
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors.

Footnote F2

The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Footnote F3

The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Footnote F4

The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.